Banook Group
Traudel Schmidt's work experience begins in 2012 when they worked at ATV GmbH as an Advanced Training Life Science Management. In 2013, they joined Lophius Biosciences GmbH as a Manager Clinical Trial Coordination and later transitioned to the role of Senior Manager Clinical Trial Coordination. During their time at Lophius Biosciences GmbH, they were responsible for managing clinical studies in Germany and Austria in various fields such as immunology, infectiology, transplantation, and autoimmune disease. Traudel'sresponsibilities included concept and budget preparation, site training and preparation, submission at authorities and ethic committees, initiation of sites, conduction control, close-out activities, evaluation, and publication. In 2021, Traudel Schmidt joined FUTRUE Research & Science GmbH as a Senior Manager Clinical Trials, where they worked until 2022. Currently, they are working at Banook Group as a Country Lead Study Manager, starting in 2022.
Traudel Schmidt pursued their education at The Julius Maximilians University of Würzburg. Traudel completed their Bachelor of Science degree in Biomedicine from 2002 to 2005. Following this, they obtained a Master of Science degree in Biomedicine from the same university between 2005 and 2007. Traudel continued their academic journey at The Julius Maximilians University of Würzburg and earned a doctoral degree, specifically a Doctor of Natural Sciences (Dr. rer. nat.), in Developmental Biochemistry from 2007 to 2012.
This person is not in any offices
Banook Group
Banook Group is one of the few established international providers capable of supplying cardiac safety, central imaging and endpoint adjudication services to pharmaceutical, medical device and biotech companies, CROs and nonprofit organizations. Its mission is to help its clients invent tomorrow’s healthcare, using qualitative, reliable and innovative solutions in early to late stage clinical trials and ultimately to bring new solutions to the market for the benefit of patients worldwide. Its medical and regulatory expertise, quality-driven approach and team availability make the Banook Group a key player for clinical trial services. Founded in 1999, Banook Group is a non-listed family company. Financially stable and strong, the group operates on an international scale, maintaining offices at its headquarters in Nancy (France) and in the United States (Mystic, CT). To learn more about the Banook Group and its subsidiaries (formerly CardiaBase, Banook Central Imaging and Banook Inc.), please visit our new website www.banookgroup.com